These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 43382)

  • 1. On an in vitro method of simulating drug release from viscous eye drops.
    MacKeen DL
    J Pharm Pharmacol; 1979 Dec; 31(12):872. PubMed ID: 43382
    [No Abstract]   [Full Text] [Related]  

  • 2. An in vitro method simulating drug release from viscous eye drops in rabbit and man.
    Melis-Decerf C; Ooteghem MV
    J Pharm Pharmacol; 1979 Jan; 31(1):12-5. PubMed ID: 32358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusidic acid in tear fluid: pharmacokinetic study with fusidic acid viscous eye drops.
    van Bijsterveld OP; Andriesse H; Nielsen BH
    Eur J Drug Metab Pharmacokinet; 1987; 12(3):215-8. PubMed ID: 3436345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of technology of sodium cromoglycate eye drops].
    Inkeniene AM; Klimas R; Ramanauskiene K
    Medicina (Kaunas); 2005; 41(7):584-91. PubMed ID: 16062026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of chloramphenicol niosomes and comparison with chloramphenicol eye drops (0.5%w/v) in experimental conjunctivitis in albino rabbits.
    Yasin MN; Hussain S; Malik F; Hameed A; Sultan T; Qureshi F; Riaz H; Perveen G; Wajid A
    Pak J Pharm Sci; 2012 Jan; 25(1):117-21. PubMed ID: 22186318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye.
    Loftsson T; Stefánsson E
    Int J Pharm; 2017 Oct; 531(2):413-423. PubMed ID: 28391041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and in vitro evaluation of cysteamine hydrochloride viscous solutions for the treatment of corneal cystinosis.
    Bozdağ S; Gümüş K; Gümüş O; Unlü N
    Eur J Pharm Biopharm; 2008 Sep; 70(1):260-9. PubMed ID: 18590953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Eye Drops Containing Disulfiram and Low-Substituted Methylcellulose in Reducing Intraocular Pressure in Rabbit Models.
    Nagai N; Yoshioka C; Mano Y; Ito Y; Okamoto N; Shimomura Y
    Curr Eye Res; 2015; 40(10):990-1000. PubMed ID: 25330366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the Safety of 2.0% Ganciclovir Eye Drops for Hospital Preparation].
    Nakagawa H; Matsumaru Y; Nose S; Sasaki H; Kitahara T
    Yakugaku Zasshi; 2018; 138(1):107-110. PubMed ID: 29311455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Viscous eye drops].
    van Woerkom CM
    Pharm Weekbl; 1972 Mar; 107(11):192-4. PubMed ID: 5015778
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of lipid peroxidation and electron microscopic survey of maturation stages during human cataractogenesis: pharmacokinetic assay of Can-C N-acetylcarnosine prodrug lubricant eye drops for cataract prevention.
    Babizhayev MA
    Drugs R D; 2005; 6(6):345-69. PubMed ID: 16274259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid eye drops inhibit growth in the newborn rabbit.
    Kugelberg M; Shafiei K; Ohlsson C; Sävendahl L; Zetterström C
    Acta Paediatr; 2005 Aug; 94(8):1096-101. PubMed ID: 16188855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysozyme in corneal ulcer.
    Mehra KS; Singh R; Bhatia RP; Sen PC; Singh H
    Ann Ophthalmol; 1975 Nov; 7(11):1470-2. PubMed ID: 1200558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop.
    Fedorchak MV; Conner IP; Schuman JS; Cugini A; Little SR
    Sci Rep; 2017 Aug; 7(1):8639. PubMed ID: 28819134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of HPMC-based pirfenidone solution in vivo.
    Yang M; Yang YF; Lei M; Ye CT; Zhao CS; Xu JG; Wu KL; Yu MB
    Drug Dev Ind Pharm; 2017 Jan; 43(1):171-176. PubMed ID: 27593737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ion-activated, Gelrite-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops.
    Sultana Y; Aqil M; Ali A
    Drug Deliv; 2006; 13(3):215-9. PubMed ID: 16556574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apraclonidine protection of the blood-aqueous barrier from traumatic break-down.
    Bonomi L; Bellucci R; Pagliarusco A; Stefani L
    J Ocul Pharmacol Ther; 1995; 11(1):25-35. PubMed ID: 8535954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on hyaluronic acid as dendifier in Shuanghuanglian eye-drops].
    Ma ML; Liu L; Sun SY
    Zhongguo Zhong Yao Za Zhi; 2005 Aug; 30(16):1246-8. PubMed ID: 16245899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term ocular toxicity and eye irritation tests following application of sufentanil in rabbits.
    Chen H; Chen Z; Xu Y
    Eye Sci; 2014 Dec; 29(4):193-7. PubMed ID: 26016069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory, antioxidant and antimicrobial activity of Ophthacare brand, an herbal eye drops.
    Mitra SK; Sundaram R; Venkataranganna MV; Gopumadhavan S; Prakash NS; Jayaram HD; Sarma DN
    Phytomedicine; 2000 Apr; 7(2):123-7. PubMed ID: 10839215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.